Amakem Nv

Amakem NV is a biopharmaceutical company that focuses on the development of novel therapeutics for the treatment of glaucoma. Their lead product candidate, AMA0076, is a kinase inhibitor designed to lower intraocular pressure in patients with glaucoma. The company is dedicated to advancing innovative solutions for ophthalmic diseases through rigorous research and development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

8 Patents

#3 in Diepenbeek

#308 in Belgium

Diepenbeek, Belgium

Amakem Nv

Forward Citations = 3

8 inventors:

Sandro Boland (8 out of 10 patents)

Dirk Leysen (8 out of 10 patents)

Olivier Defert (7 out of 9 patents)

4. Arnaud Pierre Jean Bourin (5 out of 5 patents)

5. Jo Alen (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Amakem Nv. Retrieved from https://idiyas.com/company/amakem-nv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]